DK0505377T3 - Muscarinreceptorantagonister - Google Patents

Muscarinreceptorantagonister

Info

Publication number
DK0505377T3
DK0505377T3 DK90917074.8T DK90917074T DK0505377T3 DK 0505377 T3 DK0505377 T3 DK 0505377T3 DK 90917074 T DK90917074 T DK 90917074T DK 0505377 T3 DK0505377 T3 DK 0505377T3
Authority
DK
Denmark
Prior art keywords
pct
compounds
date jun
sec
derived
Prior art date
Application number
DK90917074.8T
Other languages
Danish (da)
English (en)
Inventor
Alexander Roderick Mackenzie
Peter Cross
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0505377T3 publication Critical patent/DK0505377T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
DK90917074.8T 1989-12-12 1990-11-28 Muscarinreceptorantagonister DK0505377T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928041A GB8928041D0 (en) 1989-12-12 1989-12-12 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
DK0505377T3 true DK0505377T3 (da) 1996-02-05

Family

ID=10667812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90917074.8T DK0505377T3 (da) 1989-12-12 1990-11-28 Muscarinreceptorantagonister

Country Status (14)

Country Link
US (1) US5281601A (fr)
EP (1) EP0505377B1 (fr)
JP (1) JPH0684370B2 (fr)
AT (1) ATE132488T1 (fr)
CA (1) CA2067816C (fr)
DE (1) DE69024663T2 (fr)
DK (1) DK0505377T3 (fr)
ES (1) ES2082013T3 (fr)
FI (1) FI104719B (fr)
GB (1) GB8928041D0 (fr)
GR (1) GR3019036T3 (fr)
IE (1) IE70733B1 (fr)
PT (1) PT96143B (fr)
WO (1) WO1991009015A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
RU2230060C2 (ru) 2000-01-20 2004-06-10 Эйсай Ко., Лтд. Соединения, фармацевтическая композиция, способ предотвращения гибели нервных клеток, способ профилактики
NZ537584A (en) 2002-07-08 2006-07-28 Ranbaxy Lab Ltd 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
DE60226906D1 (de) * 2002-07-31 2008-07-10 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo ä3.1.0ühexanderivate, die sich als muscarinrezeptorantagonisten eignen
EP1545508A4 (fr) * 2002-08-09 2009-11-25 Ranbaxy Lab Ltd Derives d'azabicyclo ¬3.1.0 hexane 3,6-disubstitues, utiles en tant qu'agonistes de recepteurs muscariniques
JP2006501236A (ja) * 2002-08-23 2006-01-12 ランバクシー ラボラトリーズ リミテッド ムスカリン性レセプター拮抗薬としてのフルオロおよびスルホニルアミノ含有３，６−二置換アザビシクロ（３．１．０）ヘキサン誘導体
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
ATE400553T1 (de) * 2002-12-10 2008-07-15 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo 3.1.0 - hexanderivative als antagonisten des muscarinrezeptors
US7465751B2 (en) * 2002-12-23 2008-12-16 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
AU2002347553A1 (en) * 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1618091A1 (fr) * 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques
EA009059B1 (ru) * 2003-04-10 2007-10-26 Рэнбакси Лабораториз Лимитед Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
EP1615887A1 (fr) 2003-04-10 2006-01-18 Ranbaxy Laboratories, Ltd. Derives d'azabicyclo hexanes en tant qu'antagonistes des recepteurs muscariniques
EA009387B1 (ru) * 2003-04-11 2007-12-28 Рэнбакси Лабораториз Лимитед Азабициклические производные в качестве антагонистов мускаринового рецептора
US7368463B2 (en) * 2003-07-11 2008-05-06 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
US7234991B2 (en) * 2004-05-10 2007-06-26 Firecode Ltd. Moving toy
US20080319002A1 (en) * 2004-06-16 2008-12-25 Ranbaxy Laboratories Limited Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists
EP1781607A2 (fr) * 2004-08-19 2007-05-09 Ranbaxy Laboratories Limited Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques
US20080280883A1 (en) * 2004-09-24 2008-11-13 Mohammad Salman Muscarinic Receptor Antagonists
EP1797040A1 (fr) * 2004-09-29 2007-06-20 Ranbaxy Laboratories Limited Antagonistes de recepteurs muscariniques
US20100016400A1 (en) * 2004-11-19 2010-01-21 Naresh Kumar Azabicyclic muscarinic receptor antagonists
EP1828126A1 (fr) * 2004-12-15 2007-09-05 Ranbaxy Laboratories Limited Sels d'addition d'acide d'antagonistes du recepteur muscarinique
EP1888525A1 (fr) * 2005-05-03 2008-02-20 Ranbaxy Laboratories Limited Derives d'azabicyclo [3.1.0]hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique
JP2009512676A (ja) 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体アンタゴニストの医薬組成物
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632403A (fr) * 1962-05-17 1900-01-01
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
DE69024663D1 (de) 1996-02-15
PT96143B (pt) 1997-05-28
ES2082013T3 (es) 1996-03-16
WO1991009015A1 (fr) 1991-06-27
CA2067816C (fr) 1997-03-25
IE70733B1 (en) 1996-12-11
EP0505377A1 (fr) 1992-09-30
GB8928041D0 (en) 1990-02-14
GR3019036T3 (en) 1996-05-31
JPH0684370B2 (ja) 1994-10-26
CA2067816A1 (fr) 1991-06-13
FI922344A0 (fi) 1992-05-22
US5281601A (en) 1994-01-25
EP0505377B1 (fr) 1996-01-03
JPH05501555A (ja) 1993-03-25
FI922344A (fi) 1992-05-22
FI104719B (fi) 2000-03-31
IE904462A1 (en) 1991-06-19
DE69024663T2 (de) 1996-05-15
ATE132488T1 (de) 1996-01-15
PT96143A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
DK0505377T3 (da) Muscarinreceptorantagonister
DK0487071T3 (da) Kondenserede heterocykliske forbindelser, deres fremstilling og anvendelse
DE68910210D1 (de) (1-Hydroxy-2-piperidinylalkyl)-2-indolon, 2-quinolinon, 2-benzo[b]azepinon, 2-benzimidazolon und 2-quinazolinon-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
FI101299B (fi) Menetelmä lääkeaineina käyttökelpoisten (piperidinyylialkyyli)piperidi ini-, -pyrrolidiini-, -atsepiini- ja -atsetidiinijohdannaisten ja niid en enantiomeerien valmistamiseksi
YU29892A (sh) Postupak za stereoselektivno dobijanje supstituisanih piperidina
RU95109927A (ru) Производные 5-арилиндола и их применение в качестве агонистов серотонина (5-ht*00i)
KR900011728A (ko) 5-리폭시게나제 억제제로서의 치환된 인돌, 벤조푸란 및 벤조티오펜 유도체
DK0518558T3 (da) 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika
CO4410319A1 (es) Derivados de fenetanolamina
PT73280B (de) Neue imidazol derivate verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
KR920004394A (ko) 티에노디아제핀 이의 제조방법 및 paf-길항 활성을 지닌 약제학적 조성물로서의 이의 용도
DE68900117D1 (de) Muscarin-rezeptor-antagonisten.
PT96422A (pt) Processo para a preparacao de derivados de piperidina e de pirrolidina uteis como agentes anticolinergicos
KR910004609A (ko) 아미노케톤 유도체 및 그의 용도
GR81183B (en) (3-aryl-2,3-dihydrobenzofuran-3-yl) alkylamines, process for their preparation and their use as medicaments
ATE47391T1 (de) Neue aromatische verbindungen, ihre herstellung und verwendung.
ATA226688A (de) Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US6127379A (en) Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
AR021751A1 (es) Compuestos monociclicos, composiciones farmaceuticas que los contienen y su uso como antagonistas de receptor nk2 de taquiquinina en el tratamiento depatologias donde hay liberacion de taquiquininas
BRPI0706384A2 (pt) composto ou sais do mesmo, método para preparação do composto, e, uso do composto ou sais do mesmo
DK0462150T3 (da) Aryloxyalkylaminer, deres fremstilling og lægemidler indeholdende dem
RU93005335A (ru) Антогонисты рецептора тахикинина, изохинолины и способ их получения
ZA868243B (en) Derivatives of 3-imino-pyridazine,process for obtaining them and pharmaceutical compositions containing them
Cook I. THE MERCURIC ACETATE OXIDATION OF SUBSTITUTED PYRROLIDINES. II. THE REACTION OF DIMETHYL MALEATE WITH REPRESENTATIVE ENAMINES.